Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
Nature Medicine1997Vol. 3(8), pp. 866–871
Citations Over TimeTop 1% of 1997 papers
Yaping Chen, Terry Maguire, Ronald E. Hileman, Jonathan R. Fromm, Jeffrey D. Esko, Robert J. Linhardt, Rory M. Marks
Related Papers
- → In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination(2017)101 cited
- → Antibody-mediated enhancement of Flavivirus replication in macrophage-like cell lines(1979)201 cited
- → Profiles of antibody-dependent enhancement of dengue virus type 2 infection(1987)66 cited
- → Dengue Vaccine: The Current Status(2008)11 cited
- → Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants(1982)96 cited